About Provenance Biopharmaceuticals
Provenance Biopharmaceuticals is a biotechnology company with a focus on the development of novel immunotherapeutics. The company's main offerings include therapies designed to treat cancer and other serious, life-threatening diseases by targeting the disease at its source. The company primarily serves the healthcare industry. It is based in Waltham, Massachusetts.
Latest Provenance Biopharmaceuticals News
Dec 9, 2017
15:21 EST 9 Dec 2017 | BioPortfolio Reports Summary Provenance Biopharmaceuticals Corp Provenance is a biotechnology company that develops various novel immunotherapeutic drugs to treat cancer and other serious, lifethreatening diseases. The company offers cancer drugs based on antibodies which include avastin, erbitux, hercepton, and rituxan. Its DILeu16IL2 is an antibodycytokine fusion protein targeting the B cell antigen, CD20. The company's engineered antibody technologies promote the body's own immune system to recognize and fight disease. It offers testing of protein therapeutics in patients with nonhodgkin's lymphoma. Provenance is headquartered in Carlisle, Massachusetts, the US. Provenance Biopharmaceuticals Corp Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News
Provenance Biopharmaceuticals Frequently Asked Questions (FAQ)
Where is Provenance Biopharmaceuticals's headquarters?
Provenance Biopharmaceuticals's headquarters is located at 830 Winter Street, Waltham.
What is Provenance Biopharmaceuticals's latest funding round?
Provenance Biopharmaceuticals's latest funding round is Partnership.
Who are the investors of Provenance Biopharmaceuticals?
Investors of Provenance Biopharmaceuticals include Alopexx Enterprises.